GlassScriptPhysician profile
Bradley A King
NPI 1215357033
$16,108.65
in general payments reported to CMS, 2019-2025
15 companies · $3,750 in 2025
The $3,750 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,566 · 2020: $2,362 · 2021: $2,383 · 2022: $70.48 · 2023: $120 · 2024: $1,858 · 2025: $3,750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,360 · Travel and Lodging: $1,275 · Food and Beverage: $1,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,360.00 |
| Travel and Lodging | $1,274.81 |
| Food and Beverage | $1,092.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $3,948.20 | 2020-2021 | |
| Stryker Corporation | $3,893.50 | 2019-2025 | Mako, Aequalis Perform, Blueprint Patient Specific Instrumentation |
| Medical Device Business Services, INC. | $3,842.61 | 2019-2025 | Stratafix, Dermabond, Velys |
| Depuy Synthes Sales INC. | $1,698.89 | 2020-2025 | Attune, Velys, Va-Lcp |
| Spineart USA INC | $1,000.00 | 2019 | |
| Smith+Nephew, INC. | $612.88 | 2019-2025 | Trigen Intertan |
| Zimmer Biomet Holdings, INC. | $534.46 | 2019-2025 | Identity, Comprehensive Shoulder System |
| Dynasplint Systems INC. | $211.00 | 2021 | |
| Amarin Pharma, INC. | $177.00 | 2019 | |
| Ferring Pharmaceuticals INC. | $102.20 | 2019-2023 | Euflexxa |
| Merck Sharp & Dohme LLC | $25.26 | 2019 | |
| Curonix LLC | $20.01 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Zyla Life Sciences, INC. | $14.90 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.59 | 2025 | Breztri |
| Daiichi Sankyo INC. | $13.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.